MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

About Jochu Technology Co. Ltd. Jochu Technology Co., Ltd. engages in the manufacturing, processing, and trading of optoelectronic components, molds, and precision instruments. Its products include ...